CLINICAL_TRIALS
trial_result
· 2020-09-09
Clinical Trial Update: Efficacy and Safety of MMFS in Early AD [Phase 2]
Summary
A Phase 2 clinical trial update reports on the efficacy and safety of MMFS for Alzheimer’s disease and has completed enrollment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Neurocentria, Inc. | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED